Prevalence of Stx phages in environments of a pig farm and lysogenic infection of the field E. coli O157 isolates with a recombinant converting Phage.
The prevalence and nature of Shiga toxin (Stx)-producing Escherichia coli (STEC) and Stx phage were investigated in 720 swine fecal samples randomly collected from a commercial breeding pig farm in China over a 1-year surveillance period. Eight STEC O157 (1.1%), 33 STEC non-O157 (4.6%), and two stx-negative O157 (0.3%) isolates were identified. Fecal filtrates were screened directly for Stx phages using E. coli K-12 derivative strains MC1061 as indicator, yielding 15 Stx1 and 57 Stx2 phages. One Stx1 and eight Stx2 phages were obtained following norfloxacin induction of the eight field STEC O157 isolates. All Stx1 phages had hexagonal heads with long tails, while Stx2 phages had three different morphologies. Notably, most of field STEC O157 isolates released more free phages and Stx toxin after induction with ciprofloxacin. Furthermore, upon infection with the recombinant phage ΦMin27(Δstx::cat), E. coli laboratory strains produced both lysogenic and lytic phage, whereas two of the eight O157 STEC isolates produced only lysogens. The lysogens from laboratory strains produced infectious particles similar to ΦMin27. Similarly, the lysogens from the STEC O157 isolates released Stx phage too, although free ΦMin27(Δstx::cat) particles were not detected. Collectively, our results reveal that breeding pig farms could be important reservoirs for Stx phages and that residual antibacterial agents may enhance the release of Stx phages and the expression of Stx.
Yan
Yaxian
Y
Shanghai Key Laboratory of Veterinary Biotechnology, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai, 200240, People's Republic of China.
Shi
Yibo
Y
Cao
Dongmei
D
Meng
Xiangpeng
X
Xia
Luming
L
Sun
Jianhe
J
D000818:Animals; D000829:Animals, Domestic; D000900:Anti-Bacterial Agents / Q000378:metabolism; D002681:China; D003090:Coliphages / Q000235:genetics / Q000302:isolation & purification*; D004783:Environmental Microbiology; D048168:Escherichia coli K12 / Q000821:virology; D019453:Escherichia coli O157 / Q000302:isolation & purification / Q000821:virology*; D005243:Feces / Q000821:virology*; D008242:Lysogeny; D009643:Norfloxacin / Q000378:metabolism; D022621:Shiga Toxin / Q000235:genetics*; D013552:Swine; D010948:Viral Plaque Assay; D014764:Viral Proteins / Q000235:genetics*; D014775:Virus Activation
D000900:Anti-Bacterial Agents; D014764:Viral Proteins; D022621:Shiga Toxin; D009643:Norfloxacin